received funding from Novo Nordisk and speaking fees within the last 3 years from Novo Nordisk, Eli Lilly, Astra Zeneca, and Berlin Chemie AG
CrossRef A Combination of Plant-Derived Extracts Modulates Nutrient-Responsive Metabolic Signalling in an In Vitro GutLiverAdipose Model Francesca Uberti, Rebecca Galla, Simone Mul, Francesca Parini, Claudio Molinari Nutrients.2026
High-dose IV therapy bypasses the digestive system entirely and delivers a concentrated amount of the antioxidant directly into the bloodstream
Is MY12-OD Injection more effective than oral Vitamin B12 tablets
The blog contains sourcing guides, FDA approval status explainers, supplier reviews, comparison articles, peptide mechanism summaries, legal context, safety considerations, and research-focused educational pages that link back to relevant product and tool pages
To assess whether circulating GLP-1 has access to the OB, we administered LUXendin 645, a fluorescent GLP-1R antagonist based on Ex9 19 , intraperitoneally (IP)